Cytokine release syndrome treated with tocilizumab following ipilimumab–nivolumab combination therapy in advanced renal cell carcinoma

Introduction Cytokine release syndrome is a rare but potentially life‐threatening complication of immune checkpoint inhibitor therapy. Its occurrence in renal cell carcinoma treated with combination therapy is less recognized and poses significant management challenges. Case presentation A 50‐year‐o...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Toru Inoue, Akiko Todaka, Masahiro Fuse, Shuntaro Suzuki, Shinya Sejiyama, Tadasuke Ando, Toshitaka Shin
Format:	Artigo
Język:	Inglês
Wydane:	Wiley 2025-01-01
Seria:	IJU Case Reports
Hasła przedmiotowe:	cytokine release syndrome immune checkpoint inhibitors ipilimumab–nivolumab renal cell carcinoma tocilizumab
Dostęp online:	https://doi.org/10.1002/iju5.12812
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!